Last reviewed · How we verify
NCT05543863
Pharmacokinetics of Oral Antiplatelet Agents After Distal Gastrectomy
trial testing Platelet function testing in Stomach Neoplasm in 20 participants. Status unknown.
31 March 2023
Quick facts
| Lead sponsor | Kyungpook National University Chilgok Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 20 August 2022 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 May 2023 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Platelet function testing
Conditions studied
- Stomach Neoplasm — all drugs for Stomach Neoplasm →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Cerebrovascular Disease — all drugs for Cerebrovascular Disease →
Sponsor
Kyungpook National University Chilgok Hospital
Who can join
Adults 18 to 90, any sex, with Stomach Neoplasm or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is aimed to investigate the changes in pharmacokinetics and efficacy of antiplatelet agents before and after distal gastrectomy in gastric cancer patients taking oral antiplatelet agents for primary or secondary treatment for cardiovascular disease and to evaluate its impact on the occurrence of postoperative bleeding complications and thromboembolic events.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05543863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Platelet function testing
Trials testing the same drug.
- NCT03085524 — The Impact of Diabetes on REvascularization · completed
Other recruiting trials for Stomach Neoplasm
Currently open trials in the same condition.
- NCT06732856 — A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locall · Phase 1, PHASE2 · recruiting
- NCT06028737 — Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer · Phase 2, PHASE3 · recruiting
- NCT06923449 — Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance · recruiting
- NCT05180864 — Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer · NA · recruiting
- NCT05640609 — Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer · Phase 1, PHASE2 · recruiting
Other Kyungpook National University Chilgok Hospital trials
Trials by the same sponsor.
- NCT07066800 — Mindfulness Intervention for Maltreatment-Related Cognitive Decline · NA · active not recruiting
- NCT06903429 — Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery · NA · not yet recruiting
- NCT07511998 — A Randomized, Comparative, Controlled Study of Differences in the Incidence of Postoperative Sore Throat (POST) by Inner · NA · enrolling by invitation
- NCT06162390 — Optimal Concentration of Remifentanil for NIM Tube Intubation With Low-dose NMBA · NA · completed
- NCT05956054 — A Comparison of Intravascular Penetration With Curved Needle and Straight Needle During S1 STE · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05543863 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kyungpook National University Chilgok Hospital
- Last refreshed: 21 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05543863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing